Eradication and chronic acid suppression. Advances and pseudo-advances

Der Internist
S TuriJ F Riemann

Abstract

Guidelines for Helicobacter pylori therapy were proposed at the Maastricht 2/2000 conference. Since then no further major developments have been made. An evidenced based choice of treatment is thereby nearly impossible as large randomized trials have not been performed. Minor progress could be achieved in the areas of second-line and rescue treatment options after failure of the standard therapy. At present proton pump inhibitors are the most powerful drugs for the treatment of gastro-oesophageal reflux disease. No additional progress has been achieved concerning therapy of reflux disease in the last years. Reasonable anxiety about the safety of long-term acid suppression with proton pump inhibitors diminished over years as no significant increase in cancer development could be detected.

References

Aug 10, 2000·Alimentary Pharmacology & Therapeutics·C A Stedman, M L Barclay
Jun 14, 2001·Best Practice & Research. Clinical Gastroenterology·J Labenz
Jun 14, 2001·Best Practice & Research. Clinical Gastroenterology·S G MeuwissenE J Kuipers
Jun 22, 2001·Journal of Clinical Gastroenterology·A C Svoboda
Sep 11, 2001·Digestive Diseases·J P Gisbert, J M Pajares
Oct 31, 2001·Alimentary Pharmacology & Therapeutics·S J EdwardsL Lundell
Feb 28, 2002·Alimentary Pharmacology & Therapeutics·P MalfertheinerUNKNOWN European Helicobacter Pylori Study Group (EHPSG)
Aug 21, 2002·Expert Opinion on Pharmacotherapy·Harry Hua-Xiang XiaShiu Kum Lam
Oct 11, 2002·The New England Journal of Medicine·Sebastian Suerbaum, Pierre Michetti
Dec 11, 2002·Best Practice & Research. Clinical Gastroenterology·William Tam, John Dent
Mar 5, 2003·Alimentary Pharmacology & Therapeutics·J G Hatlebakk
Mar 29, 2003·Helicobacter·Javier P GisbertJosé María Pajares
May 20, 2003·Alimentary Pharmacology & Therapeutics·P MalfertheinerUNKNOWN BYK Advanced Gastric Ulcer Study Group
May 21, 2003·Alimentary Pharmacology & Therapeutics·D Y GrahamH B El-Serag
Jun 26, 2003·Alimentary Pharmacology & Therapeutics·D PantoflickovaA L Blum
Jul 8, 2003·Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie·P MalfertheinerG Treiber
Oct 22, 2003·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·F ParenteG Bianchi Porro
Nov 19, 2003·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Y WatanabeM Kasuga
Dec 23, 2003·Alimentary Pharmacology & Therapeutics·H FakheriR Malekzadeh
Mar 3, 2004·World Journal of Gastroenterology : WJG·Chuan-Yong GuoMin-Zhang Zhong
May 8, 2004·Deutsche medizinische Wochenschrift·B BirknerP Malfertheiner

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.